guaifenesin and codeine phosphate solution
pai holdings, llc - guaifenesin (unii: 495w7451vq) (guaifenesin - unii:495w7451vq), codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j) - guaifenesin 100 mg in 5 ml - - temporarily relieves cough due to minor throat and bronchial irritations as may occur with the common cold or inhaled irritants - helps loosen phlegm (mucus) and thin bronchial secretions to make cough more productive
guaifenesin and dextromethorphan syrup
cardinal health - guaifenesin (unii: 495w7451vq) (guaifenesin - unii:495w7451vq) - guaifenesin 200 mg in 10 ml
tusnel dm pediatric- dextromethorphan, guiafenesin, pseudoephedrine hcl solution/ drops
llorens pharmaceutical international division - guaifenesin (unii: 495w7451vq) (guaifenesin - unii:495w7451vq), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f), dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots) - guaifenesin 25 mg in 1 ml - - temporary relief of cough due to minor throat and bronchial irritation. - temporarily relieves nasal congestion due to the common cold and thin bronchial secretions to make coughs more productive. - helps loosen phlegm (mucus) and thin bronchial secretions to make cough more productive. - heart disease - high blood pressure - thyroid disease - diabetes - a cough that occurs with too much phlegm (mucus) - a persistent or chronic cough such as occurs with asthma - do not exceed recommended dosage - nervousness, dizziness or sleeplessness occurs - symptoms do not get better within 7 days or accompanied by fever - cough last more than 7 days, comes back, or is accompanied by fever, rash or persistent headache. a persistent cough could be a sign of a serious condition. - store at controlled room temperature 20° - 25° c (68° - 77° f); excursions permitted to 15° - 30° c (59° - 86° f) [see usp controlled room temperature] - tamper evident by imprinted heat seal under cap. do not use if there is evidence of tam
guaifenesin dm dextromethorphan tablet
pd-rx pharmaceuticals, inc. - guaifenesin (unii: 495w7451vq) (guaifenesin - unii:495w7451vq) - guaifenesin 400 mg
guaifenesin dm- guaifenesin and dextromethorphan solution
pharmaceutical associates, inc. - guaifenesin (unii: 495w7451vq) (guaifenesin - unii:495w7451vq), dextromethorphan (unii: 7355x3rots) (dextromethorphan - unii:7355x3rots) - guaifenesin 200 mg in 5 ml - - temporarily relieves cough due to minor throat and bronchial irritation as may occur with a cold - helps loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubes
guaifenesin extended release extended release- guaifenesin tablet, extended release
ncs healthcare of ky, inc dba vangard labs - guaifenesin (unii: 495w7451vq) (guaifenesin - unii:495w7451vq) - guaifenesin 600 mg - expectorant helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
guaifenesin liquid
cardinal health - guaifenesin (unii: 495w7451vq) (guaifenesin - unii:495w7451vq) - guaifenesin 300 mg in 15 ml
guaifenesin liquid
method pharmaceuticals, llc - guaifenesin (unii: 495w7451vq) (guaifenesin - unii:495w7451vq) - guaifenesin 100 mg in 5 ml - expectorant - helps loosen phlegm (mucus) and thin bronchial secretions to make coughs more productive.
guaifenesin phenylephrine dextromethorphan hcl tablet coated
kramer novis. - guaifenesin (unii: 495w7451vq) (guaifenesin - unii:495w7451vq) - guaifenesin 400 mg
flowtuss- hydrocodone bitartrate, guaifenesin liquid
mission pharmacal company - guaifenesin (unii: 495w7451vq) (guaifenesin - unii:495w7451vq), hydrocodone bitartrate (unii: no70w886kk) (hydrocodone - unii:6yks4y3wq7) - guaifenesin 200 mg in 5 ml - flowtuss is indicated for the symptomatic relief of cough and to loosen mucus associated with the common cold in patients 18 years of age and older. important limitations of use: - not indicated for pediatric patients under 18 years of age [ see use in specific populations (8.4) ]. - hypersensitivity to hydrocodone, guaifenesin, or any of the inactive ingredients in flowtuss [ see adverse reactions (6) ]. teratogenic effects pregnancy category c there are no adequate and well controlled studies of flowtuss in pregnant women. reproductive toxicity studies have not been conducted with flowtuss; however, studies are available with an individual active ingredient or related active ingredient. hydrocodone was teratogenic in hamsters. codeine, an opiate related to hydrocodone, increased resorptions and decreased fetal weight in rats. because animal reproduction studies are not always predictive of human response, flowtuss should be used during pregnancy only if the benefit justifies the potential risk to th